Global Nasal Drug Delivery Market Is Poised To Touch A Valuation Of USD 1.59 Billion By 2023

Jan 14, 2019

MRFR is the Leading Brand in The Research Company who Recently Published Nasal Drug Delivery Market Research Reports which includes Study of growth, Regional Analysis, Top Industry Players Formation, Major Drivers, Upcoming Trends and Forecast to 2023.

Pune, India - January 14, 2019 /MarketersMedia/ —

Market Scenario

The nasal route administration is experiencing tremendous growth due to its noninvasive nature consequently reducing pain and threat of infections. It allows the patient to self-administer drugs thus not requiring any external help. The high vasculature, high permeability, and low enzymatic environment of nasal cavity are perfectly apt for systemic delivery of drug molecules via nose. There is no risk of drug destruction by hydrogen chloride (HCl) present in the stomach thereby increasing bioavailability which reduces the dosage of the drug. This, in turn, leads to proportional reduction in side effects.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/2696

Increasing popularity of over-the-counter nasal drugs such as inhalers for the common cold is also propel the market in an upward manner. Nasal drugs prove to be advantageous for the market, with a plethora of factors like good penetration of the drugs into the nasal cavity, improving patient compliance, rapid absorption, onset of action, and requirement of low dosage.

Key Players

Novartis AG
Pfizer, Inc.
Sanofi-Aventis
Merck & Co., Inc.
AptarGroup Inc.
Johnson & Johnson Services, Inc.
GlaxoSmithKline plc
Becton Dickson & Company
 
Drivers and Restraints

The market for nasal drug delivery is growing remarkably with a consistently good CAGR due to the benefits accompanying nasal drugs.  Other driving factors include innovation of drugs which are absorbed easily from the nasal route, innovations in advanced products which allow the delivery of precise doses and also ease of administration. However, the restraints that threaten the growth of the market are irritation of the nasal route and the low dose of the drug that can be delivered as compared to other routes of administration. Other constraints include concurrent low popularity of the route which reduces economies of scale in producing these delivery devices and low awareness. According to an extensive report by Market Research Future (MRFR), the Middle East and Africa nasal drug delivery market is presumed to reach around USD 1.59 billion in 2022 surging at a CAGR of 8.1% from 2017 to 2022. The market was estimated to be worth USD 1 billion in 2015.

Regional Analysis

UAE is the largest market for nasal drug delivery in entire Middle East and Africa nasal drug delivery Market closely followed by Egypt. The rest of Africa’s market is growing at a very fast rate due to huge unmet medical needs and growing popularity of nasal route.

Segmentation

Middle East and Africa nasal drug delivery market has been segmented on the basis of dosage form which comprises of drops, sprays, powder, gels and ointments. On the basis of system, market is segmented into unit dose, multi-dose and metered dose. On the basis of delivery technologies; market is segmented into spray, nebulizers and other. On the basis of therapeutic applications; market is segmented into rhinitis, congestion, vaccinations and others.

Browse Complete 84 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/nasal-drug-delivery-market-2696

Detailed Table of Contents:

1 Introduction

1.1 Definition

1.2 Scope Of Study

1.2.1 Research Objective

1.2.2 Assumptions & Limitations

1.2.2.1 Assumptions

1.2.2.2 Limitations

1.3 Market Structure

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

...Continued!

Send an Enquiry @ https://www.marketresearchfuture.com/enquiry/2696

      

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Contact Us:, https://www.marketresearchfuture.com, Office No. 528, Amanora Chambers, Magarpatta Road, Hadapsar,, Pune - 411028, Maharashtra, India, Phone: +1 646 845 9312, Email: [email protected]
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/reports/nasal-drug-delivery-market-2696

Source URL: https://marketersmedia.com/global-nasal-drug-delivery-market-is-poised-to-touch-a-valuation-of-usd-159-billion-by-2023/469849

Source: MarketersMedia

Release ID: 469849

More News

When Do Rules on Historic Preservation Go Too Far?
Oct 22, 2026
When Do Rules on Historic Preservation Go Too Far?

Saratoga Springs, N.Y., stands out for its preservation efforts. But some say strict designs have become a burden for residents.

'I wasn't thinking straight' says five jobs civil servant
Oct 22, 2026
'I wasn't thinking straight' says five jobs civil servant

Kashim Chowdhury is accused of fraudulently juggling multiple public sector jobs.

Barclays cutting 5,000 jobs as it increases reliance on AI
Oct 22, 2026
Barclays cutting 5,000 jobs as it increases reliance on AI

The bank says it is using more AI leading to a 5% reduction in its workforce.

Tank barrel production returns to UK after 20 years
Oct 22, 2026
Tank barrel production returns to UK after 20 years

The defence secretary says the UK is "back in the business of making weapons" for its armed forces.

The Briefing Room
Oct 22, 2026
The Briefing Room

After mass protests and violence, what will persuade the French to accept economic reform?

Barclays to Cut 5,000 Jobs in A.I.-Driven Push to Lower Costs
Oct 22, 2026
Barclays to Cut 5,000 Jobs in A.I.-Driven Push to Lower Costs

The move is the latest illustration of a company saying it believes it can be more efficient with fewer workers because of artificial intelligence.

Zuckerberg’s Big Deal to Stay in California
Oct 22, 2026
Zuckerberg’s Big Deal to Stay in California

The agreement that Mark Zuckerberg, Meta’s chief executive, cut to stay in California underscores businesses’ fears about a major tax proposal.

What is PHP and why did it spark a global cyber-security scramble?
Oct 22, 2026
What is PHP and why did it spark a global cyber-security scramble?

AI uncovered long-hidden programming flaws, triggering a rare global cyber-security response.

Woman 'scared to turn heating on' due to oil cost
Oct 22, 2026
Woman 'scared to turn heating on' due to oil cost

Roslynn Garner-Gatley uses a hot water bottle bed socks and earlier bedtimes to stay warm.

Iowa, Usually Red, Is in Play This Midterm as Economic Woes Mount
Oct 22, 2026
Iowa, Usually Red, Is in Play This Midterm as Economic Woes Mount

The Trump administration’s policies could cost Republicans in a state that is being hit hard by expensive diesel prices and uncertainty over trade.

For Clues About How A.I. Will Change Work, Look to the Past
Oct 22, 2026
For Clues About How A.I. Will Change Work, Look to the Past

Economists hope earlier episodes of labor disruption, from the Industrial Revolution to the Great Depression, can help us prepare for the age of artificial intelligence.

Children in care to get £10 a week savings
Oct 22, 2026
Children in care to get £10 a week savings

Eligible people in the care system will be able to access the savings once they turn 18.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Manage The Numbers

Manage The Numbers is the world’s fastest-growing finance news website, featuring the latest money and market news, along with in-depth analysis so you can make the best decision.

Newsletter